For this purpose, the patient mutanome was screened using a CD8+ T cell product that was generated by ex vivo culture of patient peripheral blood mononuclear cells (PBMCs) with matched tumor organoids, resulting in the identification of two CD8+ T cell-recognized neoantigens (Supplementary Fig. 9). The gene discussed is CD8A; the disease is neoplasm.